ePrivacy and GPDR Cookie Consent by TermsFeed Generator

ADACEL POLIO

INJ SUS ISP 1X0,5ML+1PJ

SÚKL code 0244245
Name of the product ADACEL POLIO
_MA_MEDICATION_DETAIL_INFO_MED_NAME i ADACEL POLIO
Supplement INJ SUS ISP 1X0,5ML+1PJ
Strenght
Pharmaceutical form Suspension for injection in pre-filled syringe
Package 1X0,5ML+1PJ
Route Intramuscular use
Language of the pack Czech
Wrap type Pre-filled syringe
Legal status na lékařský předpis
Active substance DIPHTHERIA TOXOID (DIPHTHERIAE ANATOXINUM)
TETANUS TOXOID (TETANI ANATOXINUM)
POLIOMYELITIS VIRUS TYPE 1, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 1 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 2, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 2 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 3, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 3 INACTIVATUM)
PERTUSSIS TOXOID (PERTUSSIS ANATOXINUM)
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ (PERTUSSIS HAEMAGGLUTININUM FILAMENTOSUM)
PERTACTIN (PERTACTINUM)
FIMBRIAE TYPE 2 AND 3 (FIMBRIAE TYPI 2 ET 3)
ATC group J07CA02
ATC group name DIFTERIE-PERTUSE-POLIOMYELITIDA-TETANUS

Marketing authorisation information

Registration Number 59/ 265/19-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 09. 2021
MA Holder Sanofi Pasteur, Lyon
MA Holder country FRANCIE
Actual MA holder Sanofi Pasteur, Lyon
Actual MA holder country FRANCIE

Back to list